Please select one of the following:


For Clients:

For Advisors:

Please select one of the following:


For Clients:

For Advisors:
Close search  
  • Please enter a search term.

Please select your language preference on the right hand side

Languages - Canada

  • English
  • Français
Back
Regions
Language
  • English
  • Français
Skip to signin Skip to main content Skip to footer
Sunlife logo
  • Applications & forms
  • Contact us
  • CANADA | EN
  • Search
  • Products

    New! Check out our enhanced Fund Pages

    Mutual funds

    • Overview
    • Sun Life Granite Managed Solutions
    • Sun Life Private Investment Pools
    • Sun Life Tactical ETF Portfolios
    • Sun Life Milestone Funds
    • Sun Life MFS Funds
    • Emerging Markets Funds
    • Private Client Pricing

    Segregated funds

    • Overview
    • Sun GIF Solutions
    • Sun Lifetime Advantage
    • Investment options
    • Sun Life GIFs Products no longer for sale

    Payout annuities

    • Overview

    Insurance GICs and Trust GICs

    • Overview
    • Insurance GICs
    • Superflex
    • Income Master
    • Trust GICs
    • Sun GIC Max
    • SLF Trust GIC
  • Performance

    Mutual funds

    • Overview
    • Daily prices
    • Performance
    • Ratings
    • Fund codes

    Segregated funds

    • Overview
    • Daily prices
    • Performance
    • Ratings
    • Fund codes

    Insurance GICs and Trust GICs

    • Rates
  • Insights

    Commentary

    • All
    • Market updates
    • Portfolio insights
    • Videos & podcasts
    • Advisor knowledge hub

    Investor education

    • All
    • Getting started
    • Understanding market volatility
    • Saving for retirement
    • Your retirement income
    • Tax & estate planning

    Women's Investment Community

    • All
    • Invest in yourself
    • Industry trends
    • Invest in your health
  • Resources

    Quick Links

    • MySunLifeGIFS tool – Client
    • MySunLifeGIFS tool – Advisor

    Applications & forms

    • Overview
    • Mutual funds
    • Segregated funds
    • Payout annuities
    • Insurance GICs & Trust GICs

    Investor resources

    • Market volatility
    • Retirement Hub

    Tools & calculators

    • Overview

    Mutual Funds

    • Mutual fund illustration tool
    • Granite Solutions tool
    • Series T calculator

    Segregated Funds

    • Choose your path
    • Current income rates
    • Investment GIF e-App
    • Sun Life GIFs Proposal tool

    Advisor marketing & resources

    • Segregated funds marketing
    • Fund reviews
    • Payout annuities advisor resources
    • Trust GICs advisor resources
    • Insurance GICs advisor resources
    • Multi-product conversations

    Regulatory documents

    • Fund facts
    • Financial statements
    • Management Reports of Fund Performance and Quarterly Portfolio Disclosure
    • Simplified Prospectus
    • Proxy voting
    • Independent Review Committee (IRC) report
    • Passive Foreign Investment Company (PFIC)
  • About us

    Our story

    • Who we are
    • Investment management
    • Leadership
    • News releases
    • In the media

    Sustainability

    • Sustainability commitment
    • Sustainable investing
    • Climate action
    • Governance & engagement
    • Diversity, equity & inclusion

    In the community

    • Livebright Scholarship Program
Sign In
Skip to signin Skip to main content Skip to footer
sunlife logo
Sign In
  • Please enter a search term.
  • Sun Life Global Investment products - mutual funds, segregated funds, payout annuities, insurance & trust GICs
    • Back
    • Sun Life Global Investment products - mutual funds, segregated funds, payout annuities, insurance & trust GICs
    • Sun Life Global Investment products - mutual funds, segregated funds, payout annuities, insurance & trust GICs Overview
    • Sun Life Global Investments | Sun Life Granite Managed Solutions
    • Private Investment Pools
      • Back
      • Private Investment Pools Overview
      • Sun Life Core Advantage Credit Private Pool
      • Sun Life KBI Global Dividend Private Pool F
      • Sun Life Global Tactical Yield Private Pool A
      • Sun Life Global Tactical Yield Private Pool F
      • Sun Life KBI Global Dividend Private Pool A
      • Sun Life Core Advantage Credit Private Pool F
      • Sun Life Wellington Opportunistic Fixed Income Private Pool
      • Sun Life Real Assets Private Pool F
      • Sun Life Real Assets Private Pool
      • Sun Life Wellington Opportunistic Fixed Income Private Pool F
      • Sun Life KBI Sustainable Infrastructure Private Pool A
      • Sun Life KBI Sustainable Infrastructure Private Pool F
    • Sun Life Tactical ETF Portfolios
      • Back
      • Sun Life Tactical ETF Portfolios Overview
      • Sun Life Tactical Fixed Income ETF Portfolio A
      • Sun Life Tactical Fixed Income ETF Portfolio F
      • Sun Life Tactical Conservative ETF Portfolio A
      • Sun Life Tactical Conservative ETF Portfolio F
      • Sun Life Tactical Conservative ETF Portfolio F5
      • Sun Life Tactical Conservative ETF Portfolio T5
      • Sun Life Tactical Balanced ETF Portfolio
      • Sun Life Tactical Balanced ETF Portfolio T5
      • Sun Life Tactical Balanced ETF Portfolio F
      • Sun Life Tactical Balanced ETF Portfolio F5
      • Sun Life Tactical Equity ETF Portfolio A
      • Sun Life Tactical Equity ETF Portfolio F
      • Sun Life Tactical Growth ETF Portfolio A
      • Sun Life Tactical Growth ETF Portfolio F
    • Sun Life Milestone Funds
      • Back
      • Sun Life Milestone Funds Overview
      • Sun Life Milestone 2020
      • Sun Life Milestone 2025 Fund
      • Sun Life Milestone 2030
      • Sun Life Milestone 2035 Fund
    • Emerging Markets Funds
      • Back
      • Emerging Markets Funds Overview
      • Inside India
    • Private Client Pricing
      • Back
      • Private Client Pricing Overview
      • Private Client Program Announcement
    • Sun Life Guaranteed Investment Funds (GIFs)
      • Back
      • Sun Life Guaranteed Investment Funds (GIFs) Overview
      • Sun GIF Solutions
      • Sun Lifetime Advantage GIF
      • Sun Life GIFs Products no longer for sale
      • Sun Life GIFs Investment options
      • Sun Life GIFs Products no longer for sale
    • Payout annuities
      • Back
      • Payout annuities Overview
      • Life annuities
      • Term certain annuities
    • Insurance GICs and Trust GICs
      • Back
      • Insurance GICs and Trust GICs Overview
      • Trust GICs
      • Insurance GICs
    • Sun Life MFS funds
      • Back
      • Sun Life MFS funds Overview
      • Thank you
  • Performance
    • Back
    • Performance
    • Performance Overview
    • Mutual funds
      • Back
      • Mutual funds Overview
      • Historical Prices and distributions
      • Overview
      • Fund codes
      • Ratings
      • Performance
      • Daily prices
    • Segregated Funds
      • Back
      • Segregated Funds Overview
      • Historical prices
      • Daily prices
      • Performance
      • Fund codes
      • Overview
      • Ratings
    • Insurance and Trust GICs
      • Back
      • Insurance and Trust GICs Overview
      • Rates
  • About us
    • Back
    • About us
    • About us Overview
    • Who we are
    • Investment management
      • Back
      • Investment management Overview
      • MFS
      • Aditya Birla Sun Life Asset Management Company Pte. Ltd.
      • Nuveen
      • JPMorgan Asset Management Canada Inc
      • KBI Global Investors
      • Schroders
      • Dynamic Funds
      • Sun Life Global Investments | Investments Management | Black Rock
      • Wellington Management
      • Lazard Asset Management Canada Inc.
      • Amundi Asset Management
      • SLC Management
      • Crescent Capital Group
    • Leadership
    • LiveBright Scholarship Program
    • News
    • In the media
    • Sustainable Investing
    • Diversity, equity and inclusion
    • Sustainability commitment
      • Back
      • Sustainability commitment Overview
      • Climate Action
      • Governance & engagement
  • Insights
    • Back
    • Insights
    • Insights Overview
    • Commentary
      • Back
      • Commentary Overview
      • Videos & podcasts
      • Market updates
      • Portfolio insights
      • Advisor knowledge hub
    • Investor education
      • Back
      • Investor education Overview
      • Understanding market volatility
      • Getting started
      • Saving for retirement
      • Your retirement income
      • Tax & estate planning
    • Women's investment community
      • Back
      • Women's investment community Overview
      • Invest in yourself
      • Industry trends
      • Invest in your health
  • Resources
    • Back
    • Resources
    • Resources Overview
    • Advisor tools and calculators
      • Back
      • Advisor tools and calculators Overview
      • Series T calculator
      • Granite Managed Solutions proposal tool
      • Investment illustration tool
      • Current income rates
      • Choose your path
      • My SunLifeGIFS tool
      • Investment GIF e-App
    • Applications and forms
      • Back
      • Applications and forms Overview
      • Sales process tips and reminders
      • Advisor forms - flattened versions
    • Fund reviews
      • Back
      • Fund reviews Overview
      • Sun Life MFS International Value Fund
      • Sun Life MFS U.S. Growth Fund
      • Sun Life MFS Global Growth Fund
      • Sun Life Schroder Emerging Markets Fund
      • Granite Managed Portfolios Tactical Update
      • Sun Life Wellington Opportunistic Fixed Income Private Pool
      • Sun Life Core Advantage Credit Private Pool
      • Sun Life KBI Global Dividend Private Pool
      • Sun Life Real Assets Private Pool
      • Sun Life MFS International Opportunities Fund
      • Sun Life Granite Managed Portfolios
      • Sun Life MFS Global Value Fund
      • Sun Life MFS Global Total Return Fund
    • Regulatory documents
      • Back
      • Regulatory documents Overview
      • Fund facts guide
      • Sun Life GIFs Fund Facts
    • Segregated funds marketing
      • Back
      • Segregated funds marketing Overview
      • Segregated funds – Industry best practices for meeting clients’ needs
    • Payout annuities advisor resources
      • Back
      • Payout annuities advisor resources Overview
      • Premium source and available annuity types
      • Payment options
      • Maximum deferral periods
      • Guaranteed period
    • Trust GICs advisor resources
      • Back
      • Trust GICs advisor resources Overview
      • TFSA held by non-residents Max
      • Tax-Free Savings Account (TFSA) - Taxation upon death
      • Taxation on non-registered
    • Insurance GICs advisor resources
      • Back
      • Insurance GICs advisor resources Overview
      • Superflex/Income Master, Sun GIC Max and GIC - Comparison
      • New applications - Rate commitments
      • Subsequent cheque deposit - Investment instructions
      • Accrued income
      • Adjusted Cost Basis (ACB) - Deferred annuities
      • Annuitization
      • First sixty-day receipt information for Superflex and GIC products
      • General tax info for TFSA
      • Marriage breakdown and removal of spousal designation
      • Non-registered taxation of surrenders or withdrawals for non-residents
      • Non-residents - Non-registered annuity
      • Pension tax credit
      • Tax slip and receipt mailing schedule for all Individual products
      • Withholding tax on withdrawals from an RRSP
      • Withholding tax rates around the world
      • Six things you need to know about Insurance GICs
    • Solve for Client risks
  • Register
    • Back
    • Register
    • Register Overview
    • Registration Details
  • Our commitment to achieving net-zero greenhouse gas emissions by 2050 or sooner
  • CANADA | EN

    Please select your language preference on the right hand side

    Languages - Canada

    • English
    • Français
    Back
    Regions
    Language
    • English
    • Français
  1. Home
  2. Insights
  3. Commentary
  4. Portfolio insights
  5. MFS Insights: Amid Vaccine Skepticism, Testing is Key
Share this:
  • Share this on Facebook
  • Share this on Twitter
  • Share this on Linkedin

Portfolio insights

November 06, 2020

MFS Insights: Amid Vaccine Skepticism, Testing is Key

By Nicholas A. Demko

In this piece, MFS dives into the current progress of the development of a potential COVID-19 vaccine and how this can affect bio-technology stocks, financial markets as a whole and the world in general.

MFS Insights: Amid Vaccine Skepticism, Testing is Key
Nicholas A. Demko, CFA, Equity Research Analyst, Matthew Scholder, Equity Research Analyst & Robert M. Almeida, Jr, Portfolio Manager and Global Investment Strategist

In brief

  • Financial markets are betting that one or more successful coronavirus vaccines will help society return to normal.
  • But with vaccines come multiple challenges, not least of which is people’s willingness to be vaccinated.
  • In our view, mass testing is needed until vaccines and therapeutics are widely available and accepted. Companies in the life sciences supply chain may increase in investment attractiveness.

Most vaccine markets are monopolies or duopolies, but in the case of COVID-19, the World Health Organization reports that there are 42 vaccines in clinical evaluations and over 149 in preclinical development. This is a multihorse race, hopefully with multiple winners. It goes without saying that we hope this becomes an overcrowded market with immense competition and success for all involved. But let’s look at this through an investment lens.

The entire global vaccine market generates approximately $30 billion USD (and up) annually between 2014 and 20191. As optimism over the creation of successful coronavirus vaccines has grown, investors have priced a lot of it into biopharma stocks, adding nearly $100 billion to their market capitalizations2. If asset prices are a reflection of future cash flow probabilities, the market has discounted optimistic outcomes such as successful drug discovery, price durability and recurring revenue.

However, following regulatory approvals, vaccine makers face mass production and distribution challenges. For example, China and India manufacture the bulk of the world’s vaccines, presenting the potential for bottlenecks. As well, limitations in airfreight capacity or the need for temperature controlled delivery may slow distribution, particularly in warm-weather regions such as Africa, Asia and Central America.

Manufacturing and distribution issues aside, there is the likelihood that efficacy rates will not bring herd immunity any time soon. Exhibit 1 below is a 10-year look-back at the effectiveness of flu vaccines in the United States. Efficacy is low and has been falling for the past several years.

Exhibit 1: Flu shot efficacy diminishing

The graph shows diminishing flu shot efficacy from 2009 to 2019 with a significant dip in 2014-15 (only 19%).

Source: US Centers for Disease Control and Prevention.

Additionally, under normal circumstances, a portion of society is typically skeptical of new vaccines. And given the politicization of this disease, the percent of the population unwilling to be inoculated may be larger than normal. Hypothetically, a COVID-19 vaccine with 50% efficacy (applying a simple average from the chart above) consumed by 50% of the population would immunize only 25% of the population. While this is a simple assumption, it is material, as a 25% immunization rate would be well short of the 70% to 90% minimums often cited by epidemiologists as necessary to achieving herd immunity.

This is why society needs more COVID-19 testing. While these significant challenges — from drug discovery, to manufacturing and distribution, to garnering societal trust — are addressed, identifying those infected and isolating them early can prevent or limit contagion. Although therapeutics may accelerate recovery times and reduce hospitalizations, society may still need a step-function jump in testing.

Testing capacity has grown a lot in the U.S., according to The COVID Tracking Project, the U.S. saw exponential growth in testing during the spring and early summer. While the rate of growth has decelerated recently, the recent seven-day moving average is just under one million tests a day. That still is not enough.

According to a report by Duke University and The Rockefeller Foundation, asymptomatic people transmit approximately 30% to 60% of cases. The report concludes that given current infection rates, the U.S. needs around 200 million tests a month compared with the current trend of about 25 million. Given a reasonable possibility that the United States may be experiencing meaningful community spread of the virus for some time to come, the best approach to resuming “normal” life would be mass testing.

With focus on vaccines, test manufacturers underappreciated

While biotechnology stocks — and perhaps financial markets overall — have discounted high probabilities of successful vaccine discovery, we think investors may be underappreciating the potential opportunity for COVID-19 test manufacturers and services companies.

A handful of the largest life science companies in the U.S. not only develop, manufacture and distribute the global supply of COVID-19 testing supplies but also develop, manufacture and quality-check vaccines and therapeutics. We don’t think it’s a coincidence that the current management of the virus through testing and the future management of the virus through vaccination are enabled by the same kinds of highly innovative companies that support modern scientific advancement.

We believe companies in the global life sciences supply chain could potentially create sustainable profits than those in the highly-competitive vaccine market. While much of their current testing-related sales will be one-time in nature as society manages through the pandemic toward mass vaccination and natural immunity, the investments, innovation and future growth fueled by short-term virus-related revenues may potentially enable these companies to build on their long histories of investing in innovative, sustainable and high-returning endeavors.

Sources

1 https://www.statista.com/statistics/265102/revenues-in-the-global-vaccine-market/

2 https://www.barrons.com/articles/a-covid-19-vaccine-is-coming-and-investors-are-betting-big-brace-yourself-51598631049

Important Information

MFS or MFS Investment Management refers to MFS Investment Management Canada Limited and MFS Institutional Advisors, Inc.  This article was first published in the United States by MFS. in October 2020 and is distributed in Canada by SLGI Asset Management Inc., with permission. This document is provided for information purposes only and is not intended to provide specific financial, tax, insurance, investment, legal or accounting advice and should not be relied upon in that regard and does not constitute a specific offer to buy and/or sell securities.

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the fund’s prospectus. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.

The views expressed in this commentary are those of the authors and are subject to change at any time. Views expressed regarding a particular company, security, industry or market sector should not be considered an indication of trading intent of any mutual funds managed by SLGI Asset Management Inc. or sub-advised by MFS. These views are not to be considered as investment advice nor should they be considered a recommendation to buy or sell. Information presented has been compiled from sources believed to be reliable, but no representation or warranty, express or implied, is made with respect to its timeliness or accuracy. This document may contain forward-looking statements about the economy and/or markets; their future performance, strategies or prospects. Forward-looking statements are not guarantees of future performance, are speculative in nature and cannot be relied upon. They involve inherent risks and uncertainties so it is possible that predictions, forecasts, and projections will not be achieved. A number of important factors could cause actual events or results to differ materially from those expressed or implied this document.  The views expressed in this commentary are those of the authors and are subject to change at any time.

The MFS® logo is a trademark of The Massachusetts Financial Services Company and is used with permission.

Sun Life Global Investments is a trade name of SLGI Asset Management Inc., Sun Life Assurance Company of Canada and Sun Life Financial Trust Inc.

SLGI Asset Management Inc. is the investment manager of the Sun Life Mutual Funds, Sun Life Granite Managed Solutions and Sun Life Private Investment Pools.

© SLGI Asset Management Inc. and its licensors, 2020. SLGI Asset Management Inc., MFS  are  members of the Sun Life group of companies. All rights reserved.

Nicholas A. Demko, CFA, Equity Research Analyst, Matthew Scholder, Equity Research Analyst & Robert M. Almeida, Jr, Portfolio Manager and Global Investment Strategist

Related Articles

MFS Week in Review
Sun Life Global Investments wins four FundGrade A+® Awards
MFS - Capital Markets View
Why does income diversification matter?
Resources
  • Stay Diversified

  • Advisor tools and calculators

  • Fund reviews

Are you an advisor?
  • Subscribe to our emails

    Get the latest news, insights and webcasts just for advisors right to your inbox.

I understand I can unsubscribe at any time. Sun Life Global Investments will only use your email to provide you with the information you have requested and will not contact you or use your information for any other purpose. Learn more about privacy and how we collect data to provide you with more relevant content.

Learn how we are making environmental, social and governance (ESG) factors a key part of our investment strategy

  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube

Quick links

  • Advisor sign-in
  • Client sign-in
  • Find a form
  • Newsroom
  • Rates

Regulatory Documents

  • Fund Facts
  • Information folders & contracts and supplements
  • Management Reports of Fund Performance and Quarterly Portfolio Disclosure
  • Simplified Prospectus and Annual Information Form
  • Proxy voting
  • Independent Review Committee report
  • Passive Foreign Investment Company (PFIC)

Plan sponsors, consultants & group advisors

  • Institutional investor site

Contact us

  • For all questions and inquiries, please contact us

Sun Life Global Investments is a trade name of SLGI Asset Management Inc., Sun Life Assurance Company of Canada, and Sun Life Financial Trust Inc., all of which are members of the Sun Life group of companies.

SLGI Asset Management Inc. is the investment manager of the Sun Life family of mutual funds; Sun Life Assurance Company of Canada is the issuer of guaranteed insurance contracts including Annuities, and Segregated Funds.  Sun Life Financial Trust Inc. is the issuer of Guaranteed Investment Certificates.

  • Legal
  • Privacy
  • Security
  • Fraud
  • Accessibility

© SLGI Asset Management Inc., Sun Life Assurance Company of Canada, and their licensors. All rights reserved.